Protagenic Therapeutics, Inc.\new — Investor Relations & Filings
Filings indexed
678
across all filing types
Latest filing
2026-03-02
Regulatory Filings
Country
US
United States of America
Listing
US
PTIX
Protagenic Therapeutics, Inc. is a biopharmaceutical company focused on developing peptide-based therapeutics for stress-related disorders. The company's core technology is its TCAP (teneurin C-terminal associated peptide) platform, which utilizes neuropeptides to regulate the brain's stress response at a cellular level. This approach aims to counteract the 'Stress Feedback Loop' implicated in various neuropsychiatric and neurodegenerative conditions. Its lead drug candidate, PT00114, a synthetic TCAP, is being developed as a potential first-in-class treatment for disorders such as anxiety and depression.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - PROTAGENIC THERAPEUTICS, INC.\NEW (0001022899) (Filer) | 2026-03-02 | English | |
| 8-K - PROTAGENIC THERAPEUTICS, INC.\NEW (0001022899) (Filer) | 2026-02-24 | English | |
| 25-NSE Filing | 2026-01-23 | English | |
| 8-K Filing | 2026-01-05 | English | |
| DEF 14A | 2025-12-05 | English | |
| 10-Q | 2025-11-26 | English |
Browse filings by year
30 years- 2026 4 filings
- 2025 42 filings
- 2024 34 filings
- 2023 11 filings
- 2022 13 filings
- 2021 51 filings
- 2020 29 filings
- 2019 24 filings
- 2018 14 filings
- 2017 29 filings
- 2016 52 filings
- 2015 8 filings
- 2014 14 filings
- 2012 12 filings
- 2011 47 filings
- 2010 49 filings
- 2009 42 filings
- 2008 53 filings
- 2007 52 filings
- 2006 15 filings
- 2005 11 filings
- 2004 2 filings
- 2003 7 filings
- 2002 12 filings
- 2001 7 filings
- 2000 7 filings
- 1999 7 filings
- 1998 12 filings
- 1997 11 filings
- 1996 7 filings
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
4 filings
| |||||
| 32885539 | 8-K - PROTAGENIC THERAPEUTICS, INC.\NEW (0001022899) (Filer) | 2026-03-02 | English | ||
| 32885540 | 8-K - PROTAGENIC THERAPEUTICS, INC.\NEW (0001022899) (Filer) | 2026-02-24 | English | ||
| 26337506 | 25-NSE Filing | 2026-01-23 | English | ||
| 26337475 | 8-K Filing | 2026-01-05 | English | ||
|
2025
11 filings
| |||||
| 10785418 | DEF 14A | 2025-12-05 | English | ||
| 10785427 | 10-Q | 2025-11-26 | English | ||
| 10785431 | 8-K | 2025-11-26 | English | ||
| 10785432 | NT 10-Q | 2025-11-14 | English | ||
| 10785435 | 8-K | 2025-11-05 | English | ||
| 10785462 | 8-K | 2025-10-31 | English | ||
| 10785437 | 424B5 | 2025-10-24 | English | ||
| 10785463 | PRIMARY DOCUMENT | 2025-10-24 | English | ||
| 10785465 | 8-K/A | 2025-09-17 | English | ||
| 10785472 | 10-QT | 2025-09-10 | English | ||
| 10785475 | 8-K/A | 2025-08-28 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
AIM ImmunoTech Inc.
Immuno-pharma company developing therapeutics for oncology,…
|
AIM | US | Professional, scientific and te… |
|
Ainos, Inc.
Develops AI-driven diagnostics, immune therapeutics, and te…
|
AIMD | US | Professional, scientific and te… |
|
Akela Pharma Inc.
Integrated drug developer focused on pain and inhalation, p…
|
— | CA | Professional, scientific and te… |
|
Akero Therapeutics, Inc.
Clinical-stage company developing treatments for serious me…
|
AKRO | US | Professional, scientific and te… |
|
Aladdin Healthcare Technologies SE
Develops AI-powered tools for drug discovery and diagnostic…
|
NMI | DE | Professional, scientific and te… |
|
Alamar Biosciences, Inc.
Powering precision proteomics for earliest disease detectio…
|
ALMR | US | Professional, scientific and te… |
|
Alaunos Therapeutics, Inc.
Clinical-stage immuno-oncology company developing TCR-T cel…
|
TCRT | US | Professional, scientific and te… |
|
ALGORAE PHARMACEUTICALS LIMITED
Biopharmaceutical firm using AI to develop neurodegenerativ…
|
1AI | AU | Professional, scientific and te… |
|
Aligos Therapeutics, Inc.
A clinical-stage biopharmaceutical company developing thera…
|
ALGS | US | Professional, scientific and te… |
|
Allelix Biopharmaceuticals Inc.
Biopharmaceutical R&D focused on protein-based drugs and ne…
|
ALX | CA | Professional, scientific and te… |
Protagenic Therapeutics, Inc.\new via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35299/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35299 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35299 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35299 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35299}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Protagenic Therapeutics, Inc.\new (id: 35299)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.